Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care.

Pscherer S, Kostev K, Dippel FW, Rathmann W.

Diabetes Metab Syndr Obes. 2016 Feb 19;9:17-23. doi: 10.2147/DMSO.S101370. eCollection 2016 Feb 19.

3.

Increased oxidative stress response in granulocytes from older patients with a hip fracture may account for slow regeneration.

Wang Z, Ehnert S, Ihle C, Schyschka L, Pscherer S, Nussler NC, Braun KF, Van Griensven M, Wang G, Burgkart R, Stöckle U, Gebhard F, Vester H, Nussler AK.

Oxid Med Cell Longev. 2014;2014:819847. doi: 10.1155/2014/819847. Epub 2014 Mar 2.

4.

Anti-diabetic treatment regulates pro-fibrotic TGF-β serum levels in type 2 diabetics.

Pscherer S, Freude T, Forst T, Nussler AK, Braun KF, Ehnert S.

Diabetol Metab Syndr. 2013 Aug 31;5(1):48. doi: 10.1186/1758-5996-5-48.

5.

The right choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-β1-induced cellular damage.

Ehnert S, Lukoschek T, Bachmann A, Martínez Sánchez JJ, Damm G, Nussler NC, Pscherer S, Stöckle U, Dooley S, Mueller S, Nussler AK.

Hepat Med. 2013 Mar 22;5:31-41. doi: 10.2147/HMER.S38754. eCollection 2013 Mar 22.

6.

Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?

Ehnert S, Zhao J, Pscherer S, Freude T, Dooley S, Kolk A, Stöckle U, Nussler AK, Hube R.

BMC Med. 2012 Sep 7;10:101. doi: 10.1186/1741-7015-10-101.

7.

In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment.

Pscherer S, Larbig M, von Stritsky B, Pfützner A, Forst T.

J Diabetes Sci Technol. 2012 May 1;6(3):634-40.

8.

The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting.

Kailayangiri S, Altvater B, Meltzer J, Pscherer S, Luecke A, Dierkes C, Titze U, Leuchte K, Landmeier S, Hotfilder M, Dirksen U, Hardes J, Gosheger G, Juergens H, Rossig C.

Br J Cancer. 2012 Mar 13;106(6):1123-33. doi: 10.1038/bjc.2012.57. Epub 2012 Feb 28.

9.

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany.

Pscherer S, Dietrich ES, Dippel FW, Neilson AR.

Ger Med Sci. 2010 Aug 5;8. pii: Doc17. doi: 10.3205/000106.

10.

Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance.

Pscherer S, Heemann U, Frank H.

Diabetes Care. 2010 Apr;33(4):914-9. doi: 10.2337/dc09-1381. Epub 2010 Jan 19.

11.

2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells.

Altvater B, Landmeier S, Pscherer S, Temme J, Schweer K, Kailayangiri S, Campana D, Juergens H, Pule M, Rossig C.

Clin Cancer Res. 2009 Aug 1;15(15):4857-66. doi: 10.1158/1078-0432.CCR-08-2810. Epub 2009 Jul 28.

12.

Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.

Landmeier S, Altvater B, Pscherer S, Juergens H, Varnholt L, Hansmeier A, Bollard CM, Moosmann A, Bisping G, Rossig C.

J Immunother. 2009 Apr;32(3):310-21. doi: 10.1097/CJI.0b013e31819b7c30.

13.

CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.

Altvater B, Pscherer S, Landmeier S, Niggemeier V, Juergens H, Vormoor J, Rossig C.

Clin Exp Immunol. 2006 Jun;144(3):447-57.

Supplemental Content

Loading ...
Support Center